There is no translation available.

Persistent infection references

Feng J., Wang T., Shi W., Zhang S., Sullivan D., Auwaerter P.G., Zhang Y. Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library. Emerg. Microbes Infect. 2014;3:e49. doi: 10.1038/emi.2014.53. [PMC free article] [PubMed] [Cross Ref]

Oksi J., Marjamaki M., Nikoskelainen J., Viljanen M.K. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann. Med. 1999;31:225–232. doi: 10.3109/07853899909115982. [PubMed] [Cross Ref]

Preac-Mursic V, Pfister HW, Spiegel H, Burk R, Wilske B, Reinhardt S, Bohmer R. First Isolation of Borrelia burgdorferi from an Iris Biopsy. J Clin Neuro-ophthalmol 1993;13:155-161. [PubMed]

Preac-Mursic V, Weber K, Pfister HW, Wilske B, Gross B, Baumann A, Prokop J. Survival of Borrelia burgdorferi in Antibiotically Treated Patients with Lyme borreliosis. Infection 1989;17:355-359. [PubMed]

Schmidli J., Hunziker T., Moesli P., Schaad U.B. Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis. J. Infect. Dis. 1988;158:905–906. doi: 10.1093/infdis/158.4.905. [PubMed] [Cross Ref] 


Some definitions of Terminology

✓  The secondary stage results from the dissemination of Borrelia during the early latent stage.

✓  The late stage is considered chronic if the duration is more than six months.

✓ ** (double red asterisks) indicates possibility of fatality from the condition 

© Copyright 2017. Global Network on Institutional Discrimination and Ad Hoc Committee for Health Equity in ICD11 Borreliosis Codes All Rights Reserved